摘要 |
<p>The invention relates to the use of peptides having at least 8 amino acids, which are derived from the β-subunit of human chorionic gonadotropin, referred to hereafter as β-hCG, for the preparation of a pharmaceutical composition that is intended to generate a cytotoxic T lymphocyte-mediated immune response. In addition, the invention relates to the use of such peptides, in particular those mixed with or coupled to a carrier protein, for the preparation of a vaccine composition that is intended for the prevention or treatment of cancers expressing the hCG marker. The invention also relates to the use of such peptides, in particular, as an anti-tumour drug.</p> |